BUY SAGILITY LIMITED — Manas Jaiswal
byManas JaiswalHorizon: 1–3 months28 Aug 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
7 advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · adjacent horizon·29 Sept · today
Sagility approves ₹0.10 final dividend, reappoints Hari Gopalakrishnan
NewsGoogle News·27 Sept · yesterday
2 other SEBI-registered advisors have active short-term BUY calls on this stock
Advisor consensus · same horizon·5 Sept · 3w ago
Sagility approves ₹0.10 final dividend, reappoints Hari Gopalakrishnan
NewsGoogle News·30 Aug · 4w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on SAGILITY
- BUY — Osho Krishan, Angel One22 Oct 2026 · ~2 weeks · target ₹47 · Active
- BUY — Amit Seth22 Oct 2026 · ~2 weeks · target ₹47 · SL hit
- BUY — J.P. Morgan22 Oct 2026 · ~1 year · target ₹58 · Active
- BUY — Sandeep Bhatia, Macquarie Capital Securities21 Oct 2026 · ~2 weeks · target ₹47 · Active
- BUY — Kush Bohra16 Oct 2026 · ~2 weeks · target ₹47.5 · SL hit
More from Manas Jaiswal
- BUY Zydus Lifesciences22 Oct 2026 · ~3 months · target ₹1,160 · Active
- BUY IPCA Laboratories22 Oct 2026 · ~2 weeks · target ₹2,000 · Active
- BUY Coforge22 Oct 2026 · Same day · target ₹2,010 · SL hit
- BUY Tata Consultancy Services22 Oct 2026 · ~2 weeks · target ₹2,625 · Active
- SELL SRF21 Oct 2026 · ~2 weeks · target ₹1,975 · Active

